N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Yepakati Yakanyanya Kuchena

Tsanangudzo Pfupi

N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine

CAS: 152460-09-8

Chitarisiko: Yero kana Inenge Yero Upfu

Kuchena: ≥98.0% (HPLC)

Pakati peImatinib Mesylate (CAS: 220127-57-1) mukurapa kwePhiladelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
Mashoko anoreva zvakafanana Imatinib Mesylate Intermediate;2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine
Nhamba yeCAS 152460-09-8
Nhamba yeCAT RF-PI228
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C16H13N5O2
Molecular Weight 307.31
Melting Point 188.0~193.0℃
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Yero kana Yero Hupfu
Kuchena ≥98.0% (HPLC)
Kunyorova (KF) ≤0.50%
Zvose Zvisina Kuchena ≤2.0%
Maximum Single Kusachena ≤1.0%
Residue pamoto ≤0.50%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage Pakati peImatinib Mesylate (CAS: 220127-57-1)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi weN-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine (CAS: 152460-09-8) nemhando yepamusoro.Iyo yepakati kazhinji mune synthesis yeImatinib Mesylate (CAS: 220127-57-1).
Imatinib Mesylate imorekuru diki rinovharira c-Abl protein-tyrosine kinase, Yakanyanya kurongeka yeBCR-ABL, iyo enzyme yakabatana nekusingaperi myelogenous leukemia (CML) uye mamwe mafomu eacute lymphoblastic leukemia (ALL).Chiitiko chekufambisa pakati pemakromosomes 9 ne22 chinoburitsa chromosome yePhiladelphia, iyo inobva yagadzira Bcr-Abl fusion protein ine aberrant kinase chiitiko chinosimudzira kukurumidza kuwanda kwesero.Imatinib Mesylate inosunga iyi yakakosha kinase, inomisa CML ine chekuita nekukura.Imatinib Mesylate yakaramba ichiratidzwa kuti inhibit PDGFR uye tyrosine kinases yakabatana ne c-Kit.Magadzirirwo ane Imatinib Mesylate akashandiswa mukurapa kwakasiyana kenza.

Nyora meseji yako pano ugotitumira